See respiratory decline weeks before an ED visit.
Rezpio turns everyday speech into continuous, clinician-grade respiratory signal, so your pulmonology and population health teams can act on trajectory, not on a single spirometry snapshot.
Respiratory care runs on snapshots. Disease runs on trajectory.
A spirometry every 6–12 months misses the decline you could have caught. Rezpio closes the gap, continuously, at home, with no effort from the patient.
From ambient speech to a routed clinical action.
Four stages, one continuous loop. Click through to see where the signal comes from and where it lands.
On-device signal, encrypted at rest and in transit.
Model the return for your system in seconds.
Adjust for your cohort. Reduction estimate anchored to published 30-day COPD readmission programs and Rezpio pilot data.
Modeled estimate. Actual results depend on cohort composition, workflow integration and payor mix. We'll co-develop a validated forecast with your analytics team.
Fits your stack, not the other way around.
FHIR-native, SMART on FHIR launch, SSO, and your existing care management workflows. Live in 8–12 weeks.
One platform. Four stakeholders. Same story.
Quality scores and readmission penalties without adding to clinician burden.
A trajectory view of every enrolled patient, one cockpit, not fifty phone calls.
Risk-stratify cohorts continuously; deploy interventions where they change outcomes.
FHIR-native, HITRUST-certified, single vendor to procure, no shadow IT.
- HIPAA · HITRUST r2 certified
- SOC 2 Type II
- FDA de novo pathway in progress
- Zero PHI in third-party model training
Bring continuous respiratory intelligence to your system.
A 30-minute call to model your cohort, walk your workflow, and scope a pilot. No pitch deck. Just a whiteboard.